LAS-23422-73721
4 vaccinations
8 coded responses
43 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 029 / RI
- Registered
- 2022-09-11
- Relationship
- Child or adolescent in my care
- Guardian
- XGY-13209-28116
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-08
Dose 1 — Pfizer-BioNTech
-
2022-09-11
Registered in v-safe
- 2022-09-11
- 2022-09-12
- 2022-09-17
- 2022-09-22
-
2022-09-29
Dose 2 — Pfizer-BioNTech
- 2022-09-29
- 2022-09-30
-
2022-10-01
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
-
2022-10-06
Survey response — day 7, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Survey response — day 14, dose 2, under 3MedDRA: Constipation — Feeling: GoodFree text: ConstipationMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Survey response — day 21, dose 2, under 3MedDRA: Productive cough, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Congestion/runny nose, productive coughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-27
- 2022-11-03
- 2022-11-10
-
2022-12-01
Dose 3 — Pfizer-BioNTech
- 2022-12-02
- 2022-12-03
- 2022-12-04
- 2022-12-05
- 2022-12-06
- 2022-12-07
- 2022-12-08
-
2022-12-15
Survey response — day 14, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Survey response — day 21, dose 3, under 3MedDRA: Cough, Rhinorrhoea — Feeling: GoodFree text: Cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-29
Survey response — day 28, dose 3, under 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea, Wheezing — Feeling: GoodFree text: Cough, runny nose , slight wheeze due to chest congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-05
-
2023-01-12
Survey response — day 42, dose 3, under 3MedDRA: Pyrexia, Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
- 2023-03-02
-
2023-04-20
Dose 4 — Pfizer-BioNTech
- 2023-04-20
- 2023-04-21
- 2023-04-22
- 2023-04-23
- 2023-04-24
- 2023-04-25
- 2023-04-26
- 2023-04-27
- 2023-05-04
- 2023-05-11
- 2023-05-18
-
2023-05-25
Survey response — day 35, dose 4, under 3MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
- 2023-06-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-08 | Pfizer-BioNTech | No |
| 2 | 2022-09-29 | Pfizer-BioNTech | No |
| 3 | 2022-12-01 | Pfizer-BioNTech | No |
| 4 | 2023-04-20 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Runny nose
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Constipation
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Congestion/runny nose, productive cough
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Runny nose
Release 12 (Under 3) — day 21, dose 3, under 3
Symptoms: Cough, runny nose
Release 12 (Under 3) — day 28, dose 3, under 3
Symptoms: Cough, runny nose , slight wheeze due to chest congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Constipation | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release